Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3079% above fair value
$30.85−0.67 (-2.13%)
Close on Nov 12, 2026Market cap $2.31BP/E –Yield –
Schrodinger operating margin
Operating margin is operating income as a percentage of revenue.
Schrodinger's operating margin for the twelve months ending Sep 30, 2026 was -49.6%. For fiscal 2025 it was -65.2%, against -100.8% the year before. The highest annual figure on record is -45.3% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -65.2% | +35.6 |
| FY2024 | Dec 31, 2024 | -100.8% | −18.9 |
| FY2023 | Dec 31, 2023 | -81.9% | −0.8 |
| FY2022 | Dec 31, 2022 | -81.1% | −0.3 |
| FY2021 | Dec 31, 2021 | -80.8% | −24.4 |
| FY2020 | Dec 31, 2020 | -56.4% | −11.1 |
| FY2019 | Dec 31, 2019 | -45.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -40.5% | +44.1 |
| Q2 FY2026 | Jun 30, 2026 | -70.6% | +26.1 |
| Q1 FY2026 | Mar 31, 2026 | -83.3% | +2.2 |
| Q4 FY2025 | Dec 31, 2025 | -19.7% | +3.8 |
| Q3 FY2025 | Sep 30, 2025 | -84.6% | +109.3 |
| Q2 FY2025 | Jun 30, 2025 | -96.6% | +14.8 |
| Q1 FY2025 | Mar 31, 2025 | -85.5% | +98.8 |
| Q4 FY2024 | Dec 31, 2024 | -23.5% | +16.5 |
| Q3 FY2024 | Sep 30, 2024 | -193.9% | −61.9 |
| Q2 FY2024 | Jun 30, 2024 | -111.4% | +62.3 |
| Q1 FY2024 | Mar 31, 2024 | -184.3% | −137.2 |
| Q4 FY2023 | Dec 31, 2023 | -40.0% | +10.2 |
| Q3 FY2023 | Sep 30, 2023 | -132.0% | −7.2 |
| Q2 FY2023 | Jun 30, 2023 | -173.7% | −60.7 |
| Q1 FY2023 | Mar 31, 2023 | -47.1% | +11.8 |
| Q4 FY2022 | Dec 31, 2022 | -50.2% | −1.4 |
| Q3 FY2022 | Sep 30, 2022 | -124.8% | −8.7 |
| Q2 FY2022 | Jun 30, 2022 | -113.0% | −11.1 |
| Q1 FY2022 | Mar 31, 2022 | -58.9% | +15.6 |
| Q4 FY2021 | Dec 31, 2021 | -48.8% | +1.4 |
| Q3 FY2021 | Sep 30, 2021 | -116.2% | −56.3 |
| Q2 FY2021 | Jun 30, 2021 | -101.9% | −27.9 |
| Q1 FY2021 | Mar 31, 2021 | -74.4% | −29.3 |
| Q4 FY2020 | Dec 31, 2020 | -50.2% | −19.8 |
| Q3 FY2020 | Sep 30, 2020 | -59.9% | −3.3 |
| Q2 FY2020 | Jun 30, 2020 | -74.0% | −0.5 |
| Q1 FY2020 | Mar 31, 2020 | -45.1% | −18.0 |
| Q4 FY2019 | Dec 31, 2019 | -30.4% | – |
| Q3 FY2019 | Sep 30, 2019 | -56.6% | – |
| Q2 FY2019 | Jun 30, 2019 | -73.5% | – |
| Q1 FY2019 | Mar 31, 2019 | -27.1% | – |
See a number that looks wrong?